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C
onventional root canal therapy (RCT)
has been efficacious in salvaging
teeth with a history of gross carious
lesions, trauma, and fractures that lead
to pulpal and periradicular infection.13
During RCT, the infected or inflamed pulp
tissue is removed, and the root canal space
is cleaned and shaped before it is filled with
gutta percha (GP), a rubber-based filling
material with root canal cements. The final
obturation step is a crucial step in endodon-
tic therapy because the therapeutic outcome
depends on sealing the root canal space
along the length of the root canal. While
there are many benefits associated with sav-
ing natural dentition through endodontic
therapies, RCTs may fail due to inadequate
sealing of infected root canals, allowing for
bacterial regrowth within the root canal sys-
tem, causing apical periodontits and abscess.
Although RCT employs powerful intraca-
nal irrigants, e.g., 6% NaOCl, to eradicate
microbial infection, it is very difficult to
achieve complete disinfection of the complex
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ABSTRACT Root canal therapy (RCT) represents a standard of
treatment that addresses infected pulp tissue in teeth and protects
against future infection. RCT involves removing dental pulp comprising
blood vessels and nerve tissue, decontaminating residually infected
tissue through biomechanical instrumentation, and root canal obtura-
tion using a filler material to replace the space that was previously
composed of dental pulp. Gutta percha (GP) is typically used as the filler
material, as it is malleable, inert, and biocompatible. While filling the
root canal space with GP is the standard of care for endodontic therapies, it has exhibited limitations including leakage, root canal reinfection, and poor
mechanical properties. To address these challenges, clinicians have explored the use of alternative root filling materials other than GP. Among the classes of
materials that are being explored as novel endodontic therapy platforms, nanodiamonds (NDs) may offer unique advantages due to their favorable
properties, particularly for dental applications. These include versatile faceted surface chemistry, biocompatibility, and their role in improving mechanical
properties, among others. This study developed a ND-embedded GP (NDGP) that was functionalized with amoxicillin, a broad-spectrum antibiotic
commonly used for endodontic infection. Comprehensive materials characterization confirmed improved mechanical properties of NDGP over unmodified
GP. In addition, digital radiography and microcomputed tomography imaging demonstrated that obturation of root canals with NDGP could be achieved
using clinically relevant techniques. Furthermore, bacterial growth inhibition assays confirmed drug functionality of NDGP functionalized with amoxicillin.
This study demonstrates a promising path toward NDGP implementation in future endodontic therapy for improved treatment outcomes.
KEYWORDS: nanomedicine . dentistry . biomaterials . drug delivery . root canal therapy . gutta percha . endodontics
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root canal anatomy.4,5 Furthermore, secondary intra-
canal structures, e.g., lateral canals and isthmuses, may
harbor established bacterial biofilm and serve as a
source of root canal reinfection, causing treatment
failures. These lateral canals exist throughout most root
canal structures and are poorly detectable in dental
radiographs. Even if detected, lateral canals are often
difficult to instrument, leaving the pre-existing bacterial
biofilms untouched.
While GP offers numerous advantages, including
biocompability, cost efficiency, ease of removal, and
a long history of use, its inability to provide adequate
seal to prevent bacterial percolation is a challenge in
endodontic therapy. For instance, inadequate root
canal seal around voids within the obturated root canal
space may allow leakage due to absence of bonding
between GP and the dentinal surface.6,7 Such voids
with leakage may allow regrowth of bacterial within
the root canals, including those in dentinal tubules, and
establish reinfection of the root canal space, causing
treatment failures. To address these possibilities of root
canal reinfection,weharnessed thefieldofnanomedicine
with a broad spectrum of powerful nanoparticle plat-
forms for drug delivery, imaging, and other applica-
tions.813We developed a nanodiamondgutta percha
composite (NDGP) embedded with nanodiamond
amoxicillin (ND-AMC) conjugates (Figure 1A), which
can reduce the likelihood of root canal reinfection
and enhance the treatment outcomes. NDs are carbon
nanoparticles that are approximately 46 nm in di-
ameter; they are waste byproducts that are readily
processed for biomedical applications.1424 Numerous
studies have shown that NDs are biocompatible plat-
forms for drug delivery and imaging, as they possess
surface chemistries suited for electrostatic adsorption
and/or covalent conjugation of various compounds.2546
Most importantly, NDs themselves have demonstrated
antimicrobial activity.47,48 Therefore, the use of biocom-
patible NDs to simultaneously sequester and localize
the activity of amoxicillin as amodel therapeutic, aswell
as confer enhanced mechanical properties to GP for
improved ease of handling during obturation, provides
Figure 1. Schematic of NDGP embedded with ND-AMC conjugates. (A) Synthesis of NDGP. A polyisoprene solution was
prepared by solvating trans-1,4,-polyisoprene in chloroform at a 1:71 (w/w) ratio of polyisoprene to chloroform. Zinc oxide
(ZnO2), barium sulfate (BaSO4), and wax were added to this solution at a 3.3:0.55:0.15 ratio. ND-AMCwas thenmixed into the
polyisoprene solution, and the final mixture was lyophilized to obtain solid NDGP. (B) NDGP can prevent bacterial
contamination after root canal therapy due to the antimicrobial properties of both ND and amoxicillin.
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a translationally relevant route toward improving en-
dodontic treatment outcomes.
Our NDGP platform integrates several important
attributes into a single filler material. These attributes
include improved mechanical properties, relative to
those of unmodified GP, and antimicrobial activity
against oral bacterial flora (Figure 1B). By taking ad-
vantage of theND surface chemistry, a broad-spectrum
antibiotic, such as amoxicillin, can be adsorbed to the
ND surface (Figure 1A). Embedding amoxicillin-linked
NDs into GP may facilitate the eradication of residual
bacteria within the root canal system after completion
of obturation. NDGP may also kill bacteria entering
through the lateral canals following contact with
NDantibiotic agents. The homogeneous dispersion
of NDs throughout the GP matrix also leads to an
increase in toughness, as evidenced by mechanical
tests comparing the tensile strength of unmodified GP
and NDGP. Importantly, root canals were effectively
obturated using traditional obturation techniques
for both NDGP and unmodified GP. This was validated
by performing a conventional lateral obturation tech-
nique on human teeth after root canal cleaning and
shaping. A comparable quality and diagnostic capabil-
ity of obturation between unmodified GP and NDGP
was confirmed via digital radiography and micro-CT
imaging.
RESULTS AND DISCUSSION
NDAntibiotic Synthesis and Characterization. Two sam-
ples of ND-AMC were synthesized by mixing amoxicil-
lin and ND in 2.5 mM NaOH in two distinct ratios: (i)
5:2 w/wND to amoxicillin (5:2 ND-AMC) and (ii) 5:3 w/w
ND to amoxicillin (5:3 ND-AMC). After mixing, the ND-
AMC samples were incubated at room temperature
for 57 days to allow sufficient time for amoxicillin
incorporation with ND.
Formation of the ND-AMC complex was assessed
using dynamic light scattering (DLS) and ζ-potential
analysis. Amoxicillin sequestration by ND was accom-
panied by amarked increase in hydrodynamic size and
decrease in ζ-potential. The hydrodynamic size and
ζ-potential of unmodified ND were measured to be
46.64 ( 0.17 nm and 55.80 ( 0.37 mV, respectively
(Figure 2A). In constrast, 5:2 ND-AMC had a hydro-
dynamic size of 143.03 ( 4.21 nm and ζ-potential of
46.08 ( 1.10 mV, while 5:3 ND-AMC had a hydro-
dynamic size of 151.53 ( 1.22 nm and ζ-potential of
40.57 ( 2.94 mV (Figure 2A).
The quantity of amoxicillin loaded onto the ND
particles was calculated by subtracting the amount of
unbound amoxicillin from the initial loading amount
after completing ND-AMC synthesis. As shown in
Figure 2B, 1.30( 0.02mg/mL of amoxicillin was loaded
onto 5 mg/mL of ND from an amoxicillin loading con-
centration of 2 mg/mL (5:2 ND-AMC), while 2.10 (
0.05 mg/mL of amoxicillin was loaded onto 5 mg/mL
of ND from an amoxicillin loading concentration
of 3 mg/mL (5:3 ND-AMC). These concentration values
correspond to loading efficiencies of ∼65% for 5:2
ND-AMC and ∼70% for 5:3 ND-AMC, suggesting that
ND-AMC synthesis generates amoxicillin-linked NDs.
It is important to note that mere sequestration of
amoxicillin by ND is insufficient. The drug must
be adsorbed strongly enough such that it does not
immediately release after incorporation with ND. An
immediate burst release of amoxicillin is obstructive
to the combination of ND-AMC and GP, as the drug is
lost before the NDGP composite can be synthesized.
Cumulative amoxicillin release profiles showed that
the amoxicillin was released from ND-AMC in a sus-
tained manner over a week-long period, regardless of
the initial amoxicillin concentration (Figure 2C). Due
to its greater drug payload, the 5:3 ND-AMC sample
released 274.58 ( 6.29 μg/mL of amoxicillin over this
one-week period, a concentration greater than the
218.96 ( 37.86 μg/mL released by the 5:2 ND-AMC
sample over the same duration. However, in terms of
percentage release, the 5:3 ND-AMC sample eluted
∼13.1% of its total drug payload, whereas the 5:2
ND-AMC sample eluted ∼16.8% of its drug payload.
Despite differences in total amounts of released drug,
the percentage release values of 5:2 ND-AMC and 5:3
ND-AMC were comparably low, suggesting sustained
adsorption of amoxicillin onto the ND surface. This
interaction between amoxicillin and ND can prevent
loss of amoxicillin during NDGP synthesis.
Fourier transform infrared (FTIR) spectroscopy
analysis was performed as a final validation step for
amoxicillin loading. Vibrational peaks corresponding
to functional groups on ND, AMC, and ND-AMC were
compared (Figure 2D). The ND and ND-AMC spectra
shared similar peaks, including an OH bending vibra-
tion peak at 1632 cm1 and CdO stretching vibration
peaks from 1700 to 1800 cm1 corresponding to
ketones, esters, lactones, and carboxylic acid groups
found on ND surfaces. The spectra of amoxicillin
and ND-AMC also overlapped at peaks associated
with amoxicillin functional groups. Vibrational bands
on the ND-AMC spectra from 800 to 900 cm1 re-
presented bending vibrations of secondary and pri-
mary amine groups on amoxicillin. A series of small
amoxicillin peaks from 1000 to 1700 cm1 are also
found exclusively on the ND-AMC spectra and not the
ND spectrum. These small vibrational peaks include
CH bending vibrations from 1220 to 1250 cm1,
NCH and COOH bending vibrations from 1300 to
1380 cm1, CH3 bending vibrations from 1390 to
1400 cm1, phenolic OH bending vibrations from
1430 to 1450 cm1, benzylic CdC stretching vibra-
tions from 1500 to 1590 cm1, and ketone CdO
stretching vibrations from 1680 to 1710 cm1. These
FTIR data confirm successful loading of amoxicillin
onto NDs.
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Preparation and Evaluation of an NDGP Composite. In order
to enhance the antimicrobial and mechanical proper-
ties of GP, amoxicillin-loadedNDswere embedded into
the GP matrix. Briefly, the GP matrix was prepared
by the composition of polyisoprene, ZnO2, BaSO4, and
wax with a conventional ratio of 3.3:0.55:0.15, res-
pectively. After thoroughly mixing the components,
amoxicillin-loaded NDs were dispersed by sonication,
followed by overnight lyophilization until all solvents
were removed. After the preparation of NDGP, crucial
physical properties for endodontic materials, including
radiopacity and elastic modulus, were assessed.
In clinical procedures, radiopacity is a critically
important property of root canal filling materials. In
order to evaluate the quality of obturation, root canal
fillers should be radiopaque for the clinicians to visua-
lize the level of root canal obturation and the obtura-
tion quality. In order to determine the radiopacity of
Figure 2. Characterization of ND-AMC. (A) Dynamic light scattering analyses and ζ-potential measurements for unmodified
ND (ND-Pure) and ND-AMC samples synthesized from a 5:2 w/w ratio of ND to amoxicillin (5:2 ND-AMC) and a 5:3 w/w ratio of
ND to amoxicillin (5:3 ND-AMC). Top graph: Hydrodynamic sizes of ND-Pure, 5:2 ND-AMC, and 5:3 ND-AMCweremeasured to
be 46.64( 0.17, 143.03( 4.21, and 151.53( 1.22 nm, respectively. Bottom graph: ζ-potentials of ND-Pure, 5:2 ND-AMC, and
5:3 ND-AMC were measured to be 55.80 ( 0.37, 46.08 ( 1.10, and 40.57 ( 2.94 mV, respectively. (B) Standard curve for
amoxicillin concentrations (top) and the final amount of amoxicillin successfully loaded onto NDs (bottom). Using the
standard curve, the loading efficiency for ND-AMC was determined. For the 5:2 ND-AMC sample, 1.30 ( 0.02 mg/mL of
amoxicillin was loaded from an initial amoxicillin concentration of 2 mg/mL (∼65% efficiency). For the 5:3 ND-AMC sample,
2.10 ( 0.05 mg/mL of amoxicillin was loaded from an initial amoxicillin concentration of 3 mg/mL (∼70% efficiency). (C)
Cumulative amoxicillin release profiles for ND-AMC samples synthesized from 5:2 or 5:3 (w/w) ratios of ND to amoxicillin. For
both samples, sustained amoxicillin release was observed for 1 week, with some burst release observed during hours 15.
Although the 5:3 ND-AMC sample exhibits greater total drug release (274.58 ( 6.29 μg/mL) than the 5:2 ND-AMC sample
(218.96( 37.86μg/mL), the two samples released similar percentages of their respective amoxicillin payloads (∼16.8% for 5:2
ND-AMC and ∼13.1% for 5:3 ND-AMC). (D) FTIR spectra of (a) unmodified ND, (b) amoxicillin, (c) 5:2 ND-AMC, and (d) 5:3
ND-AMC. The FTIR spectra of bothND-AMC samplesdisplayedCdCHout-of-planebending vibrations at 820840 cm1 and
CdC stretching vibrations at 1560 and 1603 cm1, which are well matched with similar peaks on the amoxicillin spectrum.
A CdO stretching vibration found at 1628 cm1 on the spectra of both ND-AMC samples alsomatcheswell with a similar peak
found on the unmodified ND spectrum.
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NDGP, we compared the digital X-ray images of NDGP
with those of unmodified GP (Figure 3A). Both NDGP
(top in both images) and unmodified GP (bottom in
both images) showed clear radiopaque X-ray images,
which indicates that both materials have comparable
radiopacities.
A major goal of the NDGP platform was to improve
the mechanical properties of GP, which may lead to
improved handling properties during clinical imple-
mentation. In general composite materials, additives
(e.g., NDs) are associated with organic polymers, re-
inforcing the mechanical properties by enhancing the
interface strength between the additives and polymer.
We prepared NDGP with 5 and 10 wt % of NDs to
elucidate the effect that NDs would have on the elastic
modulus, tensile strength, 0.2% offset yield strength,
and percent elongation of GP (Figure 3 BF).
From the initial straight portion of stressstrain
curve, the elastic modulus of each sample was derived.
As shown in Figure 3C, the addition of 5 and 10 wt % of
ND into the GP matrix improves the elastic moduli by
49% and 247%, respectively. In addition, the tensile
strength and 0.2% offset yield strength increased 74%
and 34% for 5 wt %ND addition and 171% and 85% for
10 wt % ND addition, respectively (Figure 3D and E).
However, percent elongation of GP was decreased by
11% upon 5 wt % ND addition and 24% upon 10 wt %
ND addition (Figure 3F). Combined, these results
showed that the incorporation of NDs into the GP
matrix improved the elastic modulus and mechanical
strength of the NDGP biomaterial with a minor loss of
ductility.
Antimicrobial Efficacy Studies Using NDGP. The primary
objective of this study was to confirm amoxicillin func-
tionality following its loading onto ND and incorpora-
tion into NDGP. Various bacterial strains can be en-
countered during reinfection scenarios following root
canal therapy. Therefore, a Staphylococcus aureus
(S. aureus) strain (ATCC 6538) was selected as themodel
bacterium for this NDGP antimicrobial efficacy study, as
it has been previously observed in endodontic reinfec-
tion cases.4951 Recent studies have shown that various
S. aureus strains can express beta-lactamase, an enzyme
that hydrolyzes beta-lactams.52 Because of this beta-
lactamase expression, reported minimum inhibitory
concentrations (MICs) of amoxicillin against S. aureus
6538 have ranged from 31.250 to over 100 μg/mL.53,54
For this efficacy study, an NDGP sample was generated
with an initial ND:amoxicillin ratio of 5:6 (w/w), where
8 mg of drug was ultimately incorporated into the
NDGP sample. This quantity of loaded amoxicillin far
exceeds reported amoxicillin MICs for S. aureus 6538,
and NDGP should exhibit an inhibitory effect against
this particular strain of bacteria as long as drug func-
tionality is preserved upon incorporation into NDGP.
Two avenues of antimicrobial activity are possible
for this NDGP platform: (i) bacterial killing through
amoxicillin release from NDGP and/or (ii) contact-
mediated inhibition upon bacterial deposition onto
the NDGP surface. To determine whether or not
amoxicillin is freely eluted from the NDGP composite,
an agar diffusion test was conducted with unmodified
GP and NDGP. Neither unmodified GP nor NDGP pro-
duced a zone of inhibition after incubating on a lawn of
S. aureus for 24 h, indicating a negligible amount of
amoxicillin elution from NDGP (Figure 4A). This was an
important observation because avoidance of elution
from NDGP was a prerequisite for contact-mediated
inhibition, the desired mechanism of antimicrobial
activity for our NDGP platform.
To determine the degree by which S. aureus
was killed upon surface contact with NDGP, bacteria
were deposited onto both unmodified GP and NDGP.
Bacteria were visualized with a live/dead stain. After
70 h of contact, fluorescent images of both the un-
modified GP surface and the NDGP surface were
generated at 10 magnification. Unmodified GP ex-
hibited no apparent inhibition of S. aureus (Figure 4B,
row 1). In contrast, there was a significant amount of
bacterial death on the NDGP surface (Figure 4B, row 2).
Bacteria on the NDGP surface also formed large ag-
gregates, whereas the bacteria on the GP surface
remained dispersed. This effect may have been due
to the bacteria's attempt to minimize exposure to
the NDGP surface, hence reducing cell death.55,56
When S. aureus was treated for 24 h with amoxicillin
(150 μg/mL) or ND (10 mg/mL) alone, bacterial death
was also observed, showing that S. aureus responds
to both amoxicillin and ND treatment (Figure 4B,
rows 3 and 4). Taken together, these results suggest
that drug functionality was preserved during NDGP
synthesis and that NDGP prevents bacterial contam-
ination through a contact-mediated inhibition
mechanism.
It should bementioned that a key reason for the use
of ND particles to sequester and localize amoxicillin
activity and mediate contact-based inhibition is that
the reduction of antibiotic elution mediated by the
NDs may play an important role in reducing antibiotic
resistance. In addition, the absence of drug elution
coupled with contact-mediated inhibition reduces the
dosage of amoxicillin that is loaded into the NDGP.
At the same time, the NDs can play a structural role
in enhancing the mechanical properties of the NDGP
composite. To potentially accelerate NDGP translation
toward clinical use, the use of carbon in the oral cavity
and digestive tract has been demonstrated using
activated charcoal tablets.57 In addition, coupling anti-
biotics that have been approved for human use with
NDs may serve as a promising route for first in-human
studies of NDGP. As a novel material, the NDGP was
designed to remain confined within the root canal
to mediate contact-based inhibition. Therefore, the
NDGP minimizes contact with dental tissue beyond
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Figure 3. Radiopacity and mechanical properties of NDGP. (A) Left: Photograph of NDGP (top) and unmodified GP (bottom).
Right: Digital X-ray image of NDGP (top) and unmodified GP (bottom). An X-ray image showed that the radiopacity of NDGP
was comparable to that of unmodified GP. (B) Stressstrain curves of G, and NDGP (5 wt % ND, 10 wt % ND) obtained by
tensile test. The tests were performed with a 0.3 cm/min strain rate with sample gauge lengths set at 0.89 cm. They clearly
showed the areas under the curves of NDGPs (5% and 10%) are larger than unmodified GP, which means NDGPs are more
mechanically robust than unmodified GP. (C) Elastic moduli of GP (240( 26.3 MPa), NDGPs with 5 wt %ND (357( 52.0 MPa),
andNDGPwith 10wt%ND (833( 96.5MPa) calculated by initial linear portions of stressstrain curves. Data are represented
as mean( SD; *, p < 0.05; **, p < 0.01; ***, p < 0.005 (n = 3). (D) Tensile strengths of GP (7 ( 0.3 MPa), NDGP with 5 wt % ND
(12 ( 1.2 MPa), and NDGP with 10 wt % ND (19 ( 0.3 MPa) obtained from the highest stress point. Data are represented as
mean( SD; *, p< 0.05; **, p< 0.005; ***, p< 0.00001 (n = 3). (E) 0.2% offset yield strengths of GP (7( 0.3MPa), NDGPwith 5wt
% ND (9 ( 0.5 MPa), and NDGP with 10 wt % ND (12 ( 2.0 MPa) obtained from stresses that correspond to the points of
intersections of a stressstrain curve and lines that are parallel to the initial port of straight lines. It can be used to
approximately determine elastic limits. Data are represented as mean( SD; *, p < 0.005 (n = 3). (F) Percent elongation of GP
(10( 1.2MPa), NDGPwith 5wt%ND (9( 0.4MPa), andNDGPwith 10wt%ND (8( 0.7MPa)measured by changes in lengths
from the original length. Data are represented as mean ( SD; *, p < 0.05 (n = 3).
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the apex of the tooth that is sometimes observed with
conventional sealers. Furthermore, adding a drug di-
rectly into the sealer would likely result in drug elution
and depletion following burst release, which is not
an intended use of the NDGP platform. Subsequent
iterations of NDGP may potentially explore the use of
emerging antibacterial agents.5862
X-ray Imaging of Root Canal Obturation. Extracted human
teeth obturated with unmodified GP and NDGP were
imaged using digital radiography (XDR) to compare the
quality of obturation between the two different materi-
als. Digital X-ray imaging provides clinicians with a
preliminary two-dimensional view of obturated root
canals, allowing for detection of voids and quality of
the root canal fill.6365 Root canal obturation of human
teeth with NDGP revealed no apparent void formation
after conventional technique, e.g., lateral condensa-
tion,66 particularly in the critical apical third region
(Figure 5). This suggests that NDGP can be used for
obturation of root canals using conventional obtura-
tion techniques commonly used in clinical settings.
In addition to the comparable quality of obturation
with NDGP and unmodified GP, the radiopacities
of both materials were indistinguishable (Figure 5).
These images suggest that NDGP could be clinically
implemented using conventional endodontic therapy
procedures.
Microcomputed Tomography Imaging of Root Canal Obtura-
tion. Although digital radiography is used as a clinical
standard for determining the quality of obturation
and prognosis of endodontic therapies, periapical
radiography depicts only a two-dimensional view of
the complex root canal structures. We also employed
imaging with microcomputed tomography (μCT) to
assess the effectiveness of NDGP and unmodified GP in
root canal obturation and assessment of void forma-
tion. While μCT imaging cannot be utilized during RCT
to assess the quality of obturation, enhanced resolu-
tion offered by μCT provided important insight as part
of this study to compare the effectiveness of NDGP and
unmodified GP for root canal obturation. A minimal
number of small voids were observed in the canals
following obturation with NDGP, comparable to the
number of voids also observed in those obturated with
unmodified GP (Figure 5). The minimal voids present
in the NDGP-filled tooth were in the middle third of
the canal, which is a clinically acceptable criteria for
a successful root canal treatment.
CONCLUSION
This study demonstrated that functionalizing con-
ventional GP cones with amoxicillin-loaded NDs may
increase the success rate of endodontic therapies by
eliminating pre-existing microbes and preventing
reinfection of the root canal system. The mechanical
robustness of GP was also increased upon ND incor-
poration, improving the handling properties during
clinical implementation. Future studies will be useful in
enhancing the GP interface with the surrounding tooth
structure to ultimately improve fracture resistance in
weakened endodontically treated teeth. Because of
its antimicrobial properties and increased durability,
Figure 4. Comparison of NDGP antimicrobial properties
with that of unmodified GP. (A) Agar diffusion test con-
ducted with disks of unmodified GP and NDGP. After 24 h
of incubation, there was no observable zone of inhibition
around either disk, suggesting negligible amoxicillin re-
lease from NDGP.Therefore, bacterial inhibition was likely
achieved through a contact-mediated mechanism. (B) Re-
presentative live/dead strains of bacteria-coated GP and
bacteria-coated NDGP with relevant amoxicillin-only and
ND-only controls. The merged images (right column) were
separated into red and green channels during ImageJ
processing to distinguish between dead (red fluorescence,
middle column) and live (green fluorescence, left column)
bacteria. First row: S. aureus 6538 in contact with unmodi-
fied GP did not undergo cell death, as evidenced by the
lack of red fluorescent signal (middle). Live bacteria were
observed (left). The merged image (right) was taken at
10 magnification after 70 h of surface contact. Second row:
S. aureus 6538 in contact with NDGP experienced significant
cell death, as indicated by the presence of red fluorescent
staining (middle). Live bacteria were also present (left).
Bacterial clumping was observed. This behavior may be an
attempt by the bacteria to reduce exposure to the NDGP
surface. The merged image (right) was taken at 10 magni-
fication after 70 h of surface contact. Third row: A saline
solution containing 150 μg/mL of amoxicillin induced cell
death in S. aureus 6538 colonies. The merged image (right)
was taken at 60 magnification after 24 h of treatment.
The 60 image is representative of bacterial viability levels
observed under 10 magnification. Fourth row: A saline
solution containing 10 mg/mL nanodiamond also induced
bacterial death in S. aureus 6538 colonies. The merged
image (right) was taken at 60 magnification after 24 h of
treatment. The 60 image is representative of bacterial
viability levels observed under 10 magnification.
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NDGP may enhance the success rate of conventional
endodontic therapies and reduce the need for additional
treatments, including retreats and apical surgeries.
BecauseNDGP is compatiblewith traditional obturation
techniques, subsequent studieswill focus on the clinical
validation of NDGP.
MATERIALS AND METHODS
Materials. NDs were purchased from the NanoCarbon Re-
search Institute Co., Ltd. (Nagano, Japan) and used to prepare a
50 mg/mL aqueous ND stock solution. Phosphate buffer saline
(PBS)was purchased fromThermo Fisher Scientific (Canoga Park,
CA, USA), and fetal bovine serum (FBS) was purchased from
Gemini Bio Products (West Sacramento, CA, USA). Amoxicillin,
trans-1,4-polyisoprene, zinc oxide (ZnO2), bariumsulfate (BaSO4),
sodiumhydroxide (NaOH), and chloroformwere purchased from
Sigma-Aldrich (St. Louis, MO, USA). Unmodified gutta percha
points were purchased from SybronEndo (Glendora, CA, USA).
Microcon-30 centrifugal filters were purchased from Merck
Millipore Ltd. (Tullagreen, Carrigtwohill, IRL). For antimicrobial
efficacy studies, Staphylococcus aureus was purchased from
the American Type Culture Collection (ATCC 6538, Manassas,
VA, USA). Soybean-casein digest medium was purchased
from Becton, Dickinson and Company (Franklin Lakes, NJ, USA).
Live/dead BacLight viability assay reagent was purchased from
Thermo Fisher Scientific (catalog number L-7012). The ND stock
solution was sterilized prior to further experimentation. All other
reagents were used without further treatment.
Synthesis and Characterization of ND-AMC Conjugates. ND-AMCwas
synthesized by mixing NDs with amoxicillin at 5:2 and 5:3 (w/w)
ratios of ND to AMC in 2.5 mMNaOH. Themixture was vortexed
and incubated for 57 days at room temperature. After incuba-
tion, the mixture was centrifuged down and washed with
deionized water. The final product was collected via centrifuga-
tion at 20000g for 20 min and resuspended in water at a ratio
of 5:1 (w/v) ND to water. To quantify amoxicillin loading onto
ND, the concentration of unbound amoxicillin recovered after
the washing process was used to calculate amoxicillin loading
efficiency. The absorbance of the recovered amoxicillin super-
natant was measured by UVvis spectroscopy at 270 nm.
The concentration of unbound amoxicillin in the supernatant
was calculated from an amoxicillin standard curve with an
amoxicillin concentration range of 0 to 200 μg. The amount
of unbound amoxicillinwas subtracted from the amount loaded
to determine the concentration of amoxicillin incorporated
onto ND.
To verify amoxicillin binding to ND, Fourier transform infra-
red spectroscopy was performed with a PerkinElmer FTIR
Spectrum 2000 (PerkinElmer, Waltham, MA, USA) over a wave-
number range of 4004000 cm1. A 2 mg amount of lyophi-
lized ND-AMC samples was mixed with 100 mg of potassium
bromide (KBr) powder, and the mixed powder samples were
pressed to a thin disc for FTIR analysis. The FTIR spectra were
recorded with a resolution of 1 cm1 and an accumulation of
Figure 5. X-ray and microCT (μCT) images of patient-derived teeth samples obturated with unmodified GP and NDGP. (A)
Central incisor prepared and obturatedwith unmodified GP. Left: Three-dimensional rendering of the GP-filled central incisor
generated from a μCT image. Middle: A bucco-lingual X-ray view of the incisor revealed no visible voids within the obturated
canal. Right: μCT imaging of GP-filled central incisor revealed no visible voids within the apical region of the obturated canal,
althoughminor voids are present in themiddle third of the obturated canal. Coronal, middle, and apical cross sections do not
show any voids. (B) Central incisor prepared and obturated with NDGP. Left: Three-dimensional rendering of the NDGP-filled
central incisor generated from a μCT image. Middle: A bucco-lingual X-ray view of the incisor also revealed no visible voids
within the apical region of the obturated canal and minor voids in the middle third region. There were no discernible
differences between the X-ray images of theGP-filled central incisor and theNDGP-filled central incisor. Right: μCT imaging of
the NDGP-filled central incisor revealed no visible voidswithin the obturated canal. Coronal, middle, and apical cross sections
also contained no voids. Therewere no discernible differences between the μCT images of theGP-filled central incisor and the
NDGP-filled central incisor. (C) Premolar prepared and obturatedwith NDGP. Left: Three-dimensional rendering of the NDGP-
filled premolar generated from a μCT image. Middle: A bucco-lingual X-ray view of the incisor revealed no visible voidswithin
the obturated canal. Right: μCT imaging of the NDGP-filled premolar revealed no visible voids evenwithin the obturated oval
canal. Coronal, middle, and apical cross sections also contained no voids.
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64 scans. The hydrodynamic size and ζ-potential of ND and
ND-AMC suspensions (0.20.3 mg mL1) were also measured
with aZetasizerNanoZS (Malvern Instruments, UnitedKingdom).
Hydrodynamic size measurements were performed at 25 C
with a 173 backscattering angle. At least three size measure-
ments were performed. The mean hydrodynamic size and its
standard deviation were calculated by averaging the reported
z-average size values and determining their standard deviation.
The ζ-potential was also measured at 25 C in automatic mode.
Quantifying Drug Release from ND-AMC Conjugates. Amoxicillin
release experiments were performed in PBS solutions contain-
ing 0.5% v/v FBS. A 1 mL amount of ND-AMC solution was
centrifuged for 20 min at 14000g to obtain an ND-AMC pellet.
This ND-AMC pellet was resuspended in 1 mL of 0.5% v/v FBS/
PBS solution by gentle pipetting, followed by incubation for
1 h at 37 C. At each predetermined time point, the ND-AMC
solution was centrifuged for 20 min at 14000g, the supernatant
was recovered, and the pellet was resuspended in 1 mL of PBS
solution and incubated at 37 C until the next time point. At the
next time point, this procedure was repeated.
To determine the amount of amoxicillin released at each
time point, the recovered supernatant was filtered with Micro-
con-30 centrifugal filters to remove FBS. The absorbance value
of the amoxicillin-containing supernatant was subsequently
measured with a UVvis spectrophotometer. The concentra-
tion of amoxicillin in the supernatant was calculated accord-
ing to an amoxicillin standard curve derived from the same
release media. Cumulative amoxicillin release profiles were
generated by plotting cumulative amoxicillin concentration
release (measured inμg/mL) against predetermined timepoints
(measured in hours).
Synthesis and Characterization of NDGP. Gutta percha functiona-
lized with ND-AMC was synthesized by mixing polyisoprene,
ZnO2, BaSO4, wax, and ND-AMC. First, polyisoprene was sol-
vated in chloroform at a ratio of 1:71 (w/w) of polyisoprene to
chloroform. ZnO2, BaSO4, and wax were then added to the
polyisoprene solution at a ratio of 3.3:0.55:0.15, respectively,
with 15min of sonication after the addition of each component.
Lyophilized ND-AMC was then dispersed and sonicated into
the polyisoprene solution for 5 min to disperse any ND-AMC
aggregates. The final solution was lyophilized overnight. After
lyophilization, 2530mgof solid NDGPwas heated at 90 C and
molded into cones. NDGP was molded into fine-tipped cones,
to mimic the shape of accessory cones, using a manual rolling
procedure. However, further translation of these NDGP cones
will involve the use of industry-standard scalablemanufacturing
protocols for consistent/automated NDGP synthesis.
To measure the mechanical properties of GP and NDGP, an
InstronUniversal TestingMachine (model 5564, Instron, Canton,
MA, USA) was used. The tests were performedwith a 0.3 cm/min
strain rate with sample gauge lengths set at 0.89 cm. All cross
sectional areas were calculated from the diameter of each GP or
NDGP cone. The elastic modulus of each sample was calculated
from the initial straight portion of the sample's respective
stressstrain curve.
Validating Bacterial Response to Amoxicillin and ND Treatment.
S. aureus was grown in soybean-casein digest medium under
aerobic conditions at 37 C until late log phase. Amoxicillin and
NDwere solvated in 0.85%w/v NaCl solutions at concentrations
of 150 μg/mL and 10 mg/mL, respectively. A different dose of
amoxicillin was utilized for the antibacterial response studies
since the individual NDGP cones were loaded with lower
amoxicillin dosages for contact-mediated inhibition. Confirma-
tion of drug activity was performed on larger agar plates and
was thus performed using a larger NDGP sample. The bacteria
were resuspended in both solutions and incubated for 24 h.
After 24 h, live/dead BacLight viability assay reagent was added
to the bacterial suspensions according to the manufacturer's
protocol. A 10 μL portion of both the amoxicillin-treated
bacterial suspension and the ND-treated amoxicillin bacterial
suspension were dropped onto glass microscope slides. Glass
coverslips were placed onto the drops, and the slides were
sealed with nail polish. The slides were visualized with an
Olympus IX81 fluorescent microscope (Olympus, Tokyo, Japan)
at 60 magnification. Fluorescent images were processed
with ImageJ software (National Institutes of Health, Bethesda,
MD, USA).
Evaluating NDGP Drug Release and Antimicrobial Activity. For this
study, ND-AMC was synthesized by mixing a 5:6 (w/w) ratio
of ND and amoxicillin instead of the original 5:2 or 5:3 (w/w)
ratio. The loading efficiency of the amoxicillin was calculated
as previously described, and the ND-AMC conjugates were
incorporated with GP to synthesize NDGP containing 8 mg of
amoxicillin. To assess drug release from NDGP, S. aureus was
cultured in soybean-casein digest medium under aerobic con-
ditions at 37 C until late log phase. Then 200 μL of bacterial
suspension was dropped onto soybean-casein digest agar
plates and spread evenly over the entire plate. The plates were
incubated at 37 C until a uniform lawn of bacteria was formed.
An agar diffusion test was performed by pressing circular disks
of unmodified GP and NDGP into the agar plates. After incubat-
ing for 24 h, the agar plateswere checked for zones of inhibition.
To assess the viability of bacteria in direct contact with the
NDGP surface, S. aureus was cultured in soybean-casein digest
medium under aerobic conditions at 37 C until late log phase.
The bacteria were resuspended in 0.85% w/v NaCl, and live/
dead BacLight viability assay reagent was added to the bacterial
suspension according to the manufacturer's protocol. Flat disks
of unmodified GP and NDGP (5:6 w/w ND to AMC, synthesized
as previously described) were attached to glass microscope
slides. A 20 μL amount of bacterial suspension was pipetted
onto the NDGP and GP surfaces. Glass coverslips were placed
on the disks to evenly distribute the bacterial suspension.
The slides were sealed with nail polish and incubated for 70 h.
After incubation, the bacteria-coated surfaces of NDGP and
unmodified GP were visualized with an Olympus IX81 fluores-
cent microscope at 10 magnification. Fluorescent images
were processed with ImageJ software.
X-ray Imaging. Digital radiograph images were taken with
size 2 XDR Digital Intraoral sensors (XDR Radiology, Los Angeles,
CA, USA). The images were then transmitted and analyzed
by the XDR program. The patient-derived teeth samples were
radiographed at 0.016 Gy. This served as a clinically relevant
level of radiation that is typically observed for a digital periapical
radiograph during a conventional root canal procedure. The
X-ray sourceobject and objectsensor distances were kept
constant for all exposures per conventional sample testing
protocols.
Computed Tomography Imaging. Teeth samples were imaged
using a SkyScan 1172 μCT scanner (Bruker, Billerica, MA, USA) at
20 μm resolution, utilizing 55 kvp, 181 μA, and 0.5 Al filtration.
Volumetric image data were converted to DICOM format and
imported into the Dolphin Imaging software (Dolphin Imaging
& Management Solutions, Chatsworth, CA, USA) to generate 3D
and multiplanar reconstructed images.
Selection and Preparation of Patient-Derived Teeth Samples. Patient-
derived teeth samples were obtained in accordance with an
approved Institutional Review Board protocol (IRB #13-000241).
The extracted teeth were screened by digital radiography.
Challenging cases and teeth with multiple canals (i.e., root
curvatureposition andextent, pulp stones, calcificationof canals,
C-shaped canals, open apex, and root resorption) were excluded
so that the level of expertise of the operator did not play a factor
in the success of the root canal treatment. Out of 126 teeth,
20 teeth were radiographically assessed, out of which two
central incisors and one maxillary second premolar, all single-
canaled, were chosen to be obturated. Two central incisors were
chosen for comparison in obturation between NDGP and un-
modified GP. In addition, a maxillary premolar was also chosen
to demonstrate the quality of the obturation of NDGP in an oval
canal. One operator performed the endodontic procedure for
all three teeth to reduce technical error. All procedures were
done mounted in Acadental ModuPRO endodontic typodonts
(Acadental, Overland Park, KS, USA) to simulate clinical situations
as accurately as possible.
Cleaning and Shaping of Extracted Human Teeth. An access cavity
was prepared with #2 and #4 round burs. After the bur
penetrated into the pulp chamber, the roof of the chamber
was carefully removed. The Caulk Endo Z bur (Dentsply Inter-
national, York, PA, USA)was used to create and refine the proper
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border of the chamber. The working lengths were approxi-
mated by using the ruler feature on the XDR digital radiography
program. The initial apical file (IAF) was determined with a
stainless steel (SS) file to reach 0.5 mm from the radiographic
apex. A 10 SS file was initially used, and then the file size was
increased until it fit snugly to working length. The IAFs for the
following teeth A, B, and C were #15 (SS), #20 (SS), and #20 (SS),
respectively. A radiograph was taken to confirm that the work-
ing lengthwas reached. Then, coronal flaringwas achievedwith
Gates-Glidden 4, 3, and 2 (Dentsply International) in a crown-
down technique. Afterward, a circumferential filing technique
was used until the IAF file became loose in the canal, and then
filing was continued with the next larger file until the file
became loose. This technique was continued for the sub-
sequent files until the master apical file (MAF) was achieved. The
MAFs of teethA, B, andCwere#30, #45, and#45. A radiographwas
taken to confirm that the working length was reached.
Overall flaring was achieved in a crown-down technique
using rotary NiTi Profile ISO files (Dentsply International). Start-
ing with size 30/0.06 taper, 25/0.06 and 25/0.04 were used in
sequence with pencil pressure until about 1 mm from the
working length was achieved. An automated torque control
motor was used with a speed set to 300 for all rotary files. The
torque was set to 2.5, 0.8, and 1.7, respectively. The MAFs were
then used in circumferential filing to remove debris and blend
the apical and coronal flares evenly. After every file, the canal
was thoroughly irrigated with 5.25% sodium hypochlorite
(NaOCl) to remove debris so that apical blockages do not occur.
Root canal preparation cream (Premier, Plymouth Meeting, PA,
USA) was frequently used as an intracanal lubricant. Patency
was maintained throughout each step to prevent debris accu-
mulation in the apexes.
Obturation of Root Canals in Extracted Human Teeth. The lateral
condensation obturation technique was used. After thoroughly
drying the canal with paper points, master cones were selected.
Master cones all had tugback and reached working length
after radiographic assessment. The master cone sizes of teeth
A, B, and C were 40, 45, and 45. After eugenol Roth sealer (Roth
International Ltd., Chicago, IL, USA) was applied into the canal
with the MAF, the master cone was inserted and then the
spreader was inserted vertically until firm resistance for around
510 s and then withdrawn. While three regular gutta percha
medium-fine (MF) accessory cones were used to fill tooth A,
three MF NDGP accessory cones were also used to fill teeth B
and C. After radiographic confirmation that therewere no apical
voids, the Glick instrument was heated at its end and then
the canal orifices were seared off. While the gutta percha was
still warm, an unheated plugger was used to apply a vertical
condensation force. Then, about 12 mm of excess gutta
percha was removed below the cementoenamel junction, and
the remaining sealer in the pulp chamber was cleaned with
alcohol on a cotton pellet. The teeth were then taken out of the
ModuPRO segment for a final radiograph to assess the quality
of obturation.
Statistical Analysis. Experiments were conducted in triplicate.
Quantifiable results were averaged, and standard deviations
were calculated. Analysis ofmechanical differences betweenGP
and NDGP was conducted with an unpaired, two-tail Student's
t test. A p-value of <0.05 was considered statistically significant.
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